Indian hospital market faces a critical crunch in the number of hospital beds in comparison to the demand it faces. The hospital market in India has strong growth potential that is characterized by continual possibility of growth. Persistent growth in population necessitates the growth in both public as well as private hospital facilities to cater to population of varied economic standards residing in the country.
A gradual trend is being observed in terms of demand for quality healthcare service within the hospital market. This is not only because of changing nature of Indian patient population but also due to the booming medical tourism that India is currently catering to. As a result of these, the sector is attracting good amount of foreign investments or foreign hospital chains establishing business in the country. The Indian government is also undertaking numerous initiatives including tax incentives and budget allocations that would aid in investment inflow and betterment of the market.
Indian entrepreneurs are bringing in innovation within the hospital business by revolutionizing the approach towards healthcare delivery. Initiatives are being taken to penetrate smaller cities and towns where the private sector was hesitant to penetrate even a few years back. Primary and secondary care is being offered through specialty clinics or smaller hospitals specializing in few key areas to reduce their cost of operation yet increase revenue by carrying out more number of the selected few procedures. On the other hand, mobile hospitals and telemedicine is being popularized to reach patient population in rural and urban slum areas for delivering immediate healthcare services.
The Indian competitive landscape of the hospital market is primarily segmented into public and private. The public hospitals operating in the country provide service at a subsidized rate that enables the under privileged access reliable treatment. However, in the private segment hospital business in India is dominated by 11 key players that operate as a chain of hospitals, either regionally or nationally while other leading hospitals operate in the standalone format. With the penetration of private sector into the market, healthcare delivery is becoming intensively competitive among the private players which in turn are resulting in constant development in terms of service offered by them.

Slide 1: Executive Summary

Macro Economic Indicators
Slide 2: GDP at Factor Cost: Quarterly (2009-10 - 2012-13), Inflation Rate: Monthly (Nov 2012 - Apr 2013)
Slide 3: Gross Fiscal Deficit: Monthly (Sep 2011 - Feb 2012), Exchange Rate: Monthly (Dec 2012- May 2013)
Slide 4: Lending Rate: Annual (2009-10 - 2012-13), Trade Balance: Annual (2009-10 - 2012-13), FDI Annual (2009-10 - 2012-13)

Indian Healthcare Scenario
Slide 5: Healthcare Industry Overview, Healthcare Market Size & Growth (Value-Wise 2012-2017e), Healthcare Market -Segmentation (2011-12)
Slide 6: FDI Inflow in Indian Healthcare Segments
Slide 7: Healthcare Expenditure of Population by Economic Standard

Introduction
Slide 8-9: Classification of Hospitals

Market Overview
Slide 10: Hospital Market - Market Overview, Market Size & Growth (2011 to 2017e)
Slide 11: Public-Private Hospital Distribution Profile in India

Drivers & Challenges
Slide 12: Drivers & Challenges - Summary
Slide 13-21: Drivers
Slide 22-24: Challenges

IT Adoption
Slide 25: IT Adoption Overall Indian Healthcare and in Hospital Sector
Slide 26: Software Applications in Hospital Sector

Role of Government
Slide 27: Role of Government: Summary
Slide 28-30: Role of Government

Key Trends
Slide 31: Key Trends - Summary
Slide 32-34: Key Trends

Key Initiatives
Slide 35: Key Initiatives - Summary
Slide 36-38: Key Initiatives

Competitive Landscape
Slide 39: Porter's Five Forces Analysis
Slide 40-44: Competitive Benchmarking
Slide 45: Major Public Companies - Summary
Slide 46-53: Major Public Companies
Slide 54: Major Private Companies - Summary
Slide 55-95: Major Private Companies

Trade Fairs & Events
Slide 96: Trade Fairs & Events

Recent Transactions
Slide 97: Recent Investments and Partnerships

Strategic Insights
Slide 98-99: Strategic Insights

Appendix
Slide 100-101: Appendix

Hospital Supplies and Consumable Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Hospital Supplies and Consumable Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ma...

Hospital Treatment Fee Evaluation Services Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Hospital Treatment Fee Evaluation Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lan...

Modular Hospital Field Solutions Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Modular Hospital Field Solutions Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ma...

Hospital Location Management Software Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Hospital Location Management Software Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscap...

Asia Pacific Idiopathic Pulmonary Fibrosis Market Size, Share, Trends & Analysis by Drug Class (MAPK Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors), by Route of Administration (Oral, Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region, with Forecasts from 2024 to 2034....

Market Overview The Asia Pacific Idiopathic Pulmonary Fibrosis (IPF) Market is expected to witness substantial growth from 2024 to 2034, driven by the rising prevalence of IPF, advancements in drug development, and an increasing focus on early diagnosis and treatment. The market is proj...

Europe Idiopathic Pulmonary Fibrosis Market Size, Share, Trends & Analysis by Drug Class (MAPK Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors), by Route of Administration (Oral, Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region, with Forecasts from 2024 to 2034....

Market Overview The Europe Idiopathic Pulmonary Fibrosis (IPF) Market is expected to witness significant growth between 2024 and 2034, driven by the increasing prevalence of IPF, advancements in drug development, and improved diagnostic methods. The market is projected to reach USD XX.X...

North America Idiopathic Pulmonary Fibrosis Market Size, Share, Trends & Analysis by Drug Class (MAPK Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors), by Route of Administration (Oral, Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region, with Forecasts from 2024 to 2034....

Market Overview The North America Idiopathic Pulmonary Fibrosis (IPF) Market is projected to experience robust growth from 2024 to 2034, driven by advancements in therapeutic options, increasing prevalence of IPF, and a growing emphasis on early diagnosis and treatment. The market size ...

Global Idiopathic Pulmonary Fibrosis Market Size, Share, Trends & Analysis by Drug Class (MAPK Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors), by Route of Administration (Oral, Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region, with Forecasts from 2024 to 2034....

Market Overview The Global Idiopathic Pulmonary Fibrosis (IPF) Market is poised to experience significant growth between 2024 and 2034, driven by advancements in drug development, increasing prevalence of IPF, and heightened awareness about the disease. Valued at USD XX.XX billion in 20...

Asia Pacific Neurofibromatosis Treatment Market Size, Share, Trends & Analysis by Disease Type (Neurofibromatosis 1 (NF1), Neurofibromatosis 2 (NF2), Schwannomatosis), by Treatment (Medications, Surgery, Radiation Therapy, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region, with Forecasts from 2024 to 2034....

Market Overview The Asia Pacific Neurofibromatosis Treatment Market is anticipated to witness substantial growth from 2024 to 2034, driven by increasing awareness and diagnosis of neurofibromatosis (NF), advancements in treatment options, and a growing patient population. The market is ...

Europe Neurofibromatosis Treatment Market Size, Share, Trends & Analysis by Disease Type (Neurofibromatosis 1 (NF1), Neurofibromatosis 2 (NF2), Schwannomatosis), by Treatment (Medications, Surgery, Radiation Therapy, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region, with Forecasts from 2024 to 2034....

Market Overview The Europe Neurofibromatosis Treatment Market is projected to experience substantial growth from 2024 to 2034, driven by advancements in medical treatments, increasing prevalence of neurofibromatosis disorders, and rising awareness about these conditions. The market is e...